Supporting ECPC’s work related to research projects and other activities involving the creation and dissemination of scientific information.
Professor Fabien Calvo is currently the Emeritus Professor of Clinical Pharmacology at University of Paris Medical School. Professor Calvo has extensive expertise in the field of cancer. From April 2007 to September 2014, he was Deputy Director General of the National Cancer Institute of France (INCa), in charge of Research and Innovation Programmes. Through his contribution to two successive cancer plans, he supported precision medicine for all cancer patients in France in 2009, funding 28 regional genomic platforms, eight Comprehensive Cancer Centers, and 12 platforms for early phase clinical trials. He also launched the International Cancer Genome Consortium (ICGC) in 2008 and the Global Alliance for Genomics and Health (GA4GH) in 2010 with colleagues from the USA, Canada, UK and Germany. Professor Calvo was previously Head of the Clinical Research Department at Saint Louis Hospital in Paris and served as Chief Scientific Officer for Cancer Core Europe at Gustave Roussy Cancer Campus Grand Paris from December 2014 to August 2019. He is the author or co-author of >300 publications and reviews in biology or medical cancer research and cancer medicine policy.
I treated cancer patients for almost 40 years and did cancer research in order to change their outcome and to help patients face and understand their disease and treatment.
We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer.Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
legitimise our position of cancer patient representatives before decision-makers
build a reputation as a cancer patient expert within the scientific community
find partners sharing the same vision, values and goals to work together on projects
get the media’s attention in order to publish and disseminate our messages